English
Trade
Bharat Parenterals share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹1,138.95(3.79%)November 12, 2025 15:28:07 PM IST
- NSE
- BSE
- Vol : 2.52K (NSE + BSE)Last 20 day avg : 0.68 K
Bharat Parenterals is trading 3.79% upper at Rs 1,138.95 as compared to its last closing price. Bharat Parenterals has been trading in the price range of 1,135.00 & 1,050.50. Bharat Parenterals has given -21.19% in this year & -4.36% in the last 5 days. The company posted a net profit of 8.23 Crores in its last quarter.Listed peers of Bharat Parenterals include Divi's Laboratories (-0.24%), Cipla (0.34%), Sun Pharmaceutical Industries (0.91%).The Mutual Fund holding in Bharat Parenterals was at -% in . The MF holding has - from the last quarter. The FII holding in Bharat Parenterals was at 0.11% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Key Metrics
Updated on Nov 12, 2025, 08:40 PM UTC
- BetaMedium volatility0.92Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.54The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.09Annual dividends as a percentage of the stock price.
- P/BHigher than historical values2.41The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Bharat Parenterals News
Bharat Parenterals Financials
Financials
View allFinancials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
- Income
- Balance Sheet
- Cash Flow
Loading...
Units in the chart are in crores
Insights
- Financial
- Valuation
Company is profitable- The company's revenue grew in June quarter by 25.39% from Rs 116.00 crore to Rs 92.51 crore, year-on-year
- The company has grown its June quarter profit by 548.03% from Rs 1.27 crore to Rs 8.23 crore, year-on-year
The debt to equity of the company is higher than the industry median- Earnings are insufficient to cover the interest expenses on outstanding debt
Bharat Parenterals Technical Analysis
Pivot Level - classic
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
- R1
- 1,314.95
- R2
- 1,407.45
- R3
- 1,529.40
Pivot1,193.00
- S1
- 1,100.50
- S2
- 978.55
- S3
- 886.05
Short Term
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Considers price movement over the last 6 months
Not Available
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Trends unavailable at the moment.
Bharat Parenterals Peers
Return Comparison
Peers Comparison
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Neutral | 6,518.55 | -0.24 | 1,73,047.02 | 82.33 | 12.07 | 0.44 | 0.01 |
| Cipla | Moderately Bearish | 1,519.90 | 0.34 | 1,22,772.31 | 23.06 | 3.89 | 0.86 | 0.81 |
| Sun Pharmaceutical Industries | Bullish | 1,731.70 | 0.91 | 4,15,809.81 | 35.26 | 5.61 | 0.95 | 0.50 |
| Dr Reddy's Laboratories | Bearish | 1,229.25 | 1.48 | 1,02,590.10 | 17.66 | 2.98 | 0.67 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 3,824.50 | -0.03 | 1,29,727.66 | 62.77 | 15.94 | 0.90 | 17.62 |
Bharat Parenterals Shareholding
View AllShareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
Shareholding pattern for Bharat Parenterals is currently unavailable
Please check back later.
Shareholding Insights
- Promoter(s) holds a high stake in the company at 67.19%
- Promoter(s) have decreased the stake in the company in last 12 months
- FIIs are invested in this company
- FIIs holding is constant over the last quarter at 0.11%
- Mutual Funds are not invested in this company.
Bharat Parenterals Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-12 | Quarterly Results |
| 2025-07-28 | Quarterly Results & A.G.M. |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-10-29 | Quarterly Results |
About the company Bharat Parenterals
- IndustryBiotechnology & Drugs
- ISININE365Y01019
- BSE Code541096
- NSE Code
Bharat Parenterals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical formulations. The Company offers a range of products, including B-lactam antibiotics, anti-retroviral, cephalosporins antibiotics, antiprotozoal / anthelmintic, respiratory, antiallergic / anti histaminic / anticold, cleansing agents/skin infections, antibiotic, cardiovascular system, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastroinestinaltract / alimentary system, anti-inflammatory / anti pyretic / analgesic, supplements, central nervous system, anesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer and other. Its clients range from small biopharmaceutical startups to some pharmaceutical companies. It has a manufacturing facility spread over 30,000 square feet (sq. ft.) area with a large batch-sized capacity for general: tablets, capsules, oral liquids, eye drops, ointments, lotions, creams, and others.
Bharat Parenterals Share Price FAQs
Bharat Parenterals is trading at 1138.95 as on Wed Nov 12 2025 09:58:07. This is 3.79% upper as compared to its previous closing price of 1097.35.
The market capitalization of Bharat Parenterals is 784.96 Cr as on Wed Nov 12 2025 09:58:07.
The 52 wk high for Bharat Parenterals is 1870.00 whereas the 52 wk low is 802.00
Bharat Parenterals can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 29.66
- Dividend Yield: 0.09%
- D/E ratio: -
Bharat Parenterals reported a net profit of -12.63 Cr in 2025.
Quick Links